Reckitt Benckiser Bangladesh Ltd

Follow

NPAT fell from BDT 311 mn in Q4 CY21 to BDT 232 mn in Q4 CY22. RECKITTBEN reported a 278 bps yoy decline in EBIT margin in 9M'22 owing to high input costs offset by reduced opex. DPS stood at BDT 98 in CY22 against BDT 165 in CY21; payout declined in...

We have 13 listed Multinational Companies (MNCs). Their profits increased by c. 8% in Q3 CY22, and c. 1% in 9M CY22. Consumer staples performed better. Consumer discretionary companies and construction companies faced challenges. BATBC, UNILEVERCL, L...

Q3 CY21 Revenue stood at BDT1,301.0mn against BDT1,452.3mn in Q3 CY20, implying c10% YoY de-growth. Moreover, the quarter started with a strict lockdown which created some supply-side disruptions. In the first nine months of CY 21, Reckit’s NPAT stoo...

Q2 CY21 revenue stood at BDT1,229.0mn against BDT1,384.2mn in Q2 CY20, implying c11% YoY de-growth, underperforming our expectations. In the first six months of CY 21, Reckitt's NPAT stood at BDT293.1mn (EPS: BDT62.03), up by c8% YoY. As the earnings...

NPAT grew by 22.3% YoY amid 6.4% revenue growth, lower opex/sales, and effective tax rate. Reckitt posted Q1 CY21 NPAT of BDT138.9mn (EPS of BDT29.39) against BDT113.6mn (EPS of BDT24.04) in the same quarter previous year, surpassing our expectations...

Before the pandemic hit the country, Bangladesh's economy maintained a steady 6%+ growth rate during FY10-FY15 and 7.0%+ growth rate during FY16-FY18, and 8.15% in FY19. Bangladesh’s foreign exchange reserve reached USD 43bn landmark in December, 202...